相关实验视频

Updated: Jan 17, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

TYK2促进结肠直肠癌肝脏转移的免疫监测

Bernadette Mödl¹, Daniela Zwolanek², Katharina Schwertner²

¹Medical University of Vienna, Austria.

Cancer research

|September 24, 2025

概括

氨酸激酶2 (TYK2) 调节结直肠癌肝脏转移 (CRLM) 的免疫监测. 抑制TYK2可能会通过损害树突细胞功能和抗瘤免疫来恶化CRLM.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

结肠直肠癌肝脏转移 (CRLM) 是一个重大的临床挑战.
了解免疫系统在CRLM中的作用对于开发新疗法至关重要.

研究的目的:

在CRLM中确定免疫监测的关键调节者.
研究氨酸激酶2 (TYK2) 在CRLM发育和免疫反应中的作用.

主要方法:

使用一种基于器官的小鼠结肠直肠癌 (CRC) 移植模型.
在各种免疫和癌细胞类型中进行了TYK2的遗传删除研究.
从初级CRC和CRLM样本中分析了单细胞RNA测序数据.
评估了TYK2抑制剂deucravacitinib对CRLM的影响.

主要成果:

TYK2被确定为控制CRLM的关键因素.
在CRLM中TYK2的功能依赖于树突细胞,特别是它们通过MHC-I向CD8+T细胞呈现抗原的能力.
TYK2主要表达在参与瘤排水淋巴结内抗原呈现的树突细胞中.
在小鼠模型中,使用TYK2抑制剂deucravacitinib的治疗促进了CRLM.

结论:

在针对结直肠癌肝转移的免疫监测中,TYK2发挥着至关重要的作用.
这些发现突出了在患者使用TYK2抑制剂时促进CRLM的潜在风险.
在CRLM治疗策略的背景下,需要进一步考虑TYK2的作用.

更多相关视频

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.